Smith W Bradford is an officer of Q32 Bio Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Lyra Therapeutics, Inc.
14 Jun 24
4
Lyra Therapeutics, Inc.
5 Jul 23
4
Homology Medicines, Inc.
27 Feb 23
4
Homology Medicines, Inc.
11 Jan 23
4
Homology Medicines, Inc.
4 Jan 23
4
Lyra Therapeutics, Inc.
21 Jun 22
4
Homology Medicines, Inc.
28 Feb 22
4
Homology Medicines, Inc.
12 Jan 22
4
Lyra Therapeutics, Inc.
28 May 21
4
Homology Medicines, Inc.
9 Feb 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Jun 24 | LYRA Lyra Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.31 | 30,000 | 9.30 k | 30,000 |
23 Feb 23 | QTTB Q32 Bio | RSU Common Stock | Grant | Acquire A | No | No | 0 | 36,000 | 0.00 | 36,000 |
23 Feb 23 | QTTB Q32 Bio | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.6 | 213,000 | 340.80 k | 213,000 |
9 Jan 23 | QTTB Q32 Bio | Common Stock | Sell | Dispose S | No | Yes | 1.3912 | 3,729 | 5.19 k | 14,219 |